Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

How Much Difference Will Eli Lilly's Half-Price Insulin Make?
NPR
Sun, 03/10/19 - 12:04 pm
Tags:
Eli Lilly, insulin, diabetes, drug pricing, Humalog
3 Big Pharmas Trying to Pop the Rebate Bubble
Motley Fool
Wed, 03/6/19 - 10:06 am
Tags:
drug pricing, drug rebates, Eli Lilly, Amgen, Gilead Sciences
Lilly claims fast FDA review for Emgality in cluster headache
Pharmaforum
Tue, 03/5/19 - 11:55 am
Tags:
Eli Lilly, migraines, CGRP blockers, Emgality, episodic cluster headache
Lilly will sell a version of its popular insulin at half the price, but will this appease critics?
Stat
Mon, 03/4/19 - 10:23 am
Tags:
Eli Lilly, insulin, drug pricing, Humalog, KwikPens
In a blockbuster franchise race, Novo’s Trulicity rival scores more promising late-stage diabetes data
Endpoints
Mon, 03/4/19 - 10:20 am
Tags:
Novo Nordisk, Trulicity, Ozempic, Eli Lilly, diabetes
Johnson & Johnson keeps the heat on Tremfya's rivals with at-home injector nod
Fierce Pharma
Fri, 03/1/19 - 11:56 am
Tags:
JNJ, Janssen, Tremfya, psoriasis, Novartis, Cosentyx, Eli Lilly, Taltz
Biogen, BioMarin, Lilly and Bristol-Myers Could Be in Crosshairs of Acquirers
Yahoo/Guru Focus
Sun, 02/24/19 - 11:36 pm
Tags:
M&A, Merck, Biogen, Biomarin, Eli Lilly, Bristol-Myers Squibb
Higher dose of Pfizer-Lilly drug helps reduce back pain in study
Yahoo/Reuters
Tue, 02/19/19 - 09:54 am
Tags:
Pfizer, Eli Lilly, chronic low back pain, low back pain, clinical trials, tanezumab, opioid alternatives
Bayer acquires full Vitrakvi rights from Eli Lilly's Loxo
Yahoo/Reuters
Fri, 02/15/19 - 10:27 am
Tags:
Bayer, Vitrakvi, cancer, Eli Lilly, Loxo Oncology
Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride
Pharmaceutical Business Review
Fri, 02/15/19 - 10:13 am
Tags:
Boehringer Ingelheim, Eli Lilly, glimepiride, linagliptin, Tradjenta, type 2 diabetes, clinical trials
Pharma companies clear the R&D decks in Q4
Pharmaforum
Mon, 02/11/19 - 12:20 pm
Tags:
R&D, GSK, Sanofi, Eli Lilly, Roche, Gilead Sciences
Eli Lilly Misses Q4 Earnings, Cuts 2019 Outlook After Loxo Oncology Deal
TheStreet.com
Wed, 02/6/19 - 09:47 am
Tags:
Eli Lilly, earnings, M&A, Loxo Oncology
Lilly and Incyte's Olumiant Hits the Mark in Two Phase III Atopic Dermatitis Trials
BioSpace
Mon, 02/4/19 - 11:49 am
Tags:
Eli Lilly, Incyte, olumiant, atopic dermatitis, clinical trials
Here's Why Array BioPharma Jumped 31% in January
Motley Fool
Mon, 02/4/19 - 09:53 am
Tags:
Array Biopharma, Eli Lilly, Braftovi, Mektovi
Upcoming events – Ascendis and Lilly hope for growth with pivotal data
EP Vantage
Fri, 02/1/19 - 11:58 am
Tags:
Ascendis, clinical trials, pediatric growth hormone deficiency, TransCon hGH, Eli Lilly, olumiant, eczema
Eli Lilly Loxo Oncology Transaction Clears A Hurdle
CP Wire
Fri, 02/1/19 - 09:48 am
Tags:
Eli Lilly, Loxo Oncology, M&A
Fri, 02/1/19 - 09:43 am
Tags:
Eli Lilly, Loxo Oncology, M&A
Even with new competition, Botox can hold its own in growing migraine field: Allergan executives
Fierce Pharma
Thu, 01/31/19 - 11:48 am
Tags:
Allergan, Botox, Amgen, Eli Lilly, Teva Pharmaceuticals, migraines
Pfizer and Lilly’s tanezumab succeeds in second phase 3 osteoarthritis pain trial
Pharmaceutical Business Review
Wed, 01/30/19 - 10:05 am
Tags:
Pfizer, Eli Lilly, tanezumab, clinical trials, osteoarthritis pain, osteoarthritis
Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more
CP Wire
Sun, 01/27/19 - 07:09 pm
Tags:
earnings, drug pricing, Genentech, Eli Lilly, Medtronic, Roche, M&A, Takeda, GSK, FDA

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.